FDA approvals
2016 GLP-1 FDA approvals & regulatory actions
1 regulatory event affecting GLP-1 medications in 2016.
- Original approval
Adlyxin
Once-daily lixisenatide approved for type 2 diabetes.
Read on fda.gov →
Affiliate-supportedIndependent editorialWe never sell medicationSee how
FDA approvals
1 regulatory event affecting GLP-1 medications in 2016.
Once-daily lixisenatide approved for type 2 diabetes.
Read on fda.gov →